BB Biotech AG
BION
Rank in Stocks
#4507
BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG.... BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools. The construction of its investment portfolio is guided by a fundamental analysis approach. Established on November 9, 1993, BB Biotech AG is headquartered in Switzerland.
Share Price
$61.40
Last synced: 2026-10-21
Market Cap
$3.39B
Change (1 day)
-5.95%
Change (1 year)
25.48%
Country
CH
Trade BB Biotech AG (BION)
Category
Financial Services
EPS for BB Biotech AG (BION)
EPS as of 2026 TTM: 0
According to BB Biotech AG latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for BB Biotech AG from 2026 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $44.57 | - |
US
|
|
| - | - |
SE
|
|
| $4.50 | - |
US
|
|
| $3.36 | - |
US
|
|
| $1.74 | - |
US
|
